Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast

被引：22
作者：
Krase, Ifat Zerin [1 ]
Cavanaugh, Kevin [2 ]
Curiel-Lewandrowski, Clara [2 ]
机构：
[1] Univ Arizona, Coll Med, Tucson, AZ 85724 USA
[2] Univ Arizona, Dept Dermatol, 1501 N Campbell Ave, Tucson, AZ 85724 USA
来源：
JAMA DERMATOLOGY | 2016年 / 152卷 / 03期
关键词：
D O I：
10.1001/jamadermatol.2015.3405
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：348 / 350
页数：4
相关论文
共 6 条
[1]  
[Anonymous], 2014, OT PACK INS
[2]   Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data [J].
Askling, Johan ;
Fahrbach, Kyle ;
Nordstrom, Beth ;
Ross, Susan ;
Schmid, Christopher H. ;
Symmons, Deborah .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (02) :119-130
[3]   Treatment Options for Pityriasis Rubra Pilaris Including Biologic Agents: A Retrospective Analysis From an Academic Medical Center [J].
Eastham, A. Brooke ;
Femia, Alisa N. ;
Qureshi, Abrar ;
Vleugels, Ruth Ann .
JAMA DERMATOLOGY, 2014, 150 (01) :92-94
[4]   Pityriasis Rubra Pilaris A Review of Diagnosis and Treatment [J].
Klein, Annette ;
Landthaler, Michael ;
Karrer, Sigrid .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2010, 11 (03) :157-170
[5]   Infliximab monotherapy as adult-onset pityriasis rubra review of the literature first-line treatment for pilaris: Case report and on biologic therapy [J].
Mueller, Hansgeorg ;
Gattringer, Cornelia ;
Zelger, Bernhard ;
Hoepfl, Reinhard ;
Eisendle, Klaus .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (05) :S65-S70
[6]   New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast [J].
Palfreeman, Andrew C. ;
McNamee, Kay E. ;
McCann, Fiona E. .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 :201-210
1